Underhill Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$12.3M Buy
189,150
+39,800
+27% +$2.65M 6.51% 8
2018
Q4
$9.34M Sell
149,350
-56,500
-27% -$3.95M 5.97% 9
2018
Q3
$15.9M Buy
205,850
+400
+0.2% +$30.2K 7.8% 4
2018
Q2
$14.6M Buy
205,450
+1,850
+0.9% +$131K 6.86% 6
2018
Q1
$15.3M Sell
203,600
-1,100
-0.5% -$87.4K 7.43% 5
2017
Q4
$14.7M Sell
204,700
-1,100
-0.5% -$83.5K 6.99% 6
2017
Q3
$16.7M Hold
205,800
9.03% 2
2017
Q2
$14.6M Buy
205,800
+37,000
+22% +$2.46M 9.21% 2
2017
Q1
$11.5M Buy
168,800
+83,850
+99% +$5.9M 7.34% 6
2016
Q4
$6.08M Sell
84,950
-58,200
-41% -$4.33M 3.53% 15
2016
Q3
$11.3M Buy
143,150
+12,400
+9% +$1.01M 6.27% 8
2016
Q2
$10.9M Buy
130,750
+17,850
+16% +$1.58M 5.89% 9
2016
Q1
$10.4M Sell
112,900
-14,450
-11% -$1.3M 5.23% 11
2015
Q4
$12.9M Buy
127,350
+71,750
+129% +$7.47M 6.96% 9
2015
Q3
$5.46M Buy
+55,600
New +$6.18M 2.69% 14

Other funds holding GILD

Underhill Investment Management's GILD Position: Q1 2019 in Review

Underhill Investment Management increased its Gilead Sciences (GILD) stake by 27% in Q1 2019, buying an estimated $2.65M and bringing the position to 189,150 shares worth $12.3M. The position accounts for 6.51% of the portfolio, ranked #8.

Underhill Investment Management first reported a position in GILD in Q3 2015 and has held it in 15 quarters since. The position peaked at $16.7M in Q3 2017. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Underhill Investment Management held 189,150 shares of Gilead Sciences worth $12.3M as of Q1 2019.
  • Underhill Investment Management bought 39,800 Gilead Sciences shares in Q1 2019, an estimated $2.65M.
  • Gilead Sciences made up 6.51% of Underhill Investment Management's portfolio in Q1 2019, its #8 holding.
  • Underhill Investment Management first reported a position in Gilead Sciences in Q3 2015 and has held it in 15 quarters since.
  • Underhill Investment Management's Gilead Sciences position peaked at $16.7M in Q3 2017.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Underhill Investment Management's 13F filing for Q1 2019, filed 5 Apr 2019.